Earnings · US stocks

ImmunityBio Inc (IBRX) earnings

ImmunityBio Inc published its quarterly report on 2026-11-09. The stock moved -22.76% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-09
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-17.66%—
3 days-22.76%—
7 days-27.50%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 3 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +0.19%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-09-0.09-84.80%-22.76%——
2026-08-04-0.22-175.00%+2.38%+13.85%+13.88%
2026-05-07-0.08-20.00%-3.22%-12.17%-13.93%
2026-02-23-0.06+37.93%+9.66%-18.62%-14.20%
2025-11-04-0.07+30.00%+2.40%+1.44%+2.01%
2025-08-05-0.10—-0.21%+16.60%+12.03%
2025-05-12-0.15-7.14%+20.29%+34.78%+27.26%
2025-03-03-0.08+38.46%-6.99%-20.06%-9.92%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.